Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildapace M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Apace Life Sciences Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildapace M 500mg/50mg Tablet

Diabetic patients with type 2 mellitus may find relief with the dual-action Vildapace M 500mg/50mg Tablet, which effectively manages elevated blood glucose. This dual-therapy approach mitigates the risk of severe diabetic complications, including vision impairment and kidney disease, and potentially lessens the likelihood of cardiovascular events like stroke or heart attack. Vildapace M 500mg/50mg Tablets may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved through consistent medication use, coupled with a balanced diet and regular physical activity. Dosage is tailored to individual needs, factoring in current health status, blood sugar readings, and concomitant medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Maintaining controlled blood sugar levels is crucial for preventing future health problems. Adherence to your physician's dietary and exercise plan is paramount. Lifestyle choices significantly impact diabetes management. Commonly reported side effects encompass diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, particularly when combined with insulin or sulfonylureas, is a potential adverse event; understanding its signs and management is crucial. This medication is not universally suitable. Prior to commencing treatment, patients with pre-existing hepatic, renal, or cardiac conditions, pancreatic disorders, or significant alcohol consumption should inform their physician. Pregnant or lactating individuals require medical consultation before use. Potential drug interactions necessitate complete disclosure of all medications to the prescribing physician to ensure patient safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted by your doctor throughout the course of treatment.

Uses of Vildapace M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vildapace M 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Vildapace M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Vildapace M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildapace M 500mg/50mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Vildapace M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

How Vildapace M 500mg/50mg Tablet works:

One tablet of Vildapace M contains 500mg of one antidiabetic drug and 50mg of a second, offering dual-action glucose control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Vildapace M 500mg/50mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildapace M 500mg/50mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Vildapace M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Vildapace M 500mg/50mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is recommended.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Vildapace M 500mg/50mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vildapace M 500mg/50mg Tablet :

Should you forget to take a Vildapace M 500mg/50mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildapace M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildapace M 500mg/50mg Tablet

Vildapace M 500mg/50mg Tablets rarely cause hypoglycemia by themselves; however, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildapace M 500mg/50mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Vildapace M 500mg/50mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and securely, preventing access by children, pets, and others.
Vildapace M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18.
Vildapace M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Vildapace M 500mg/50mg Tablets and seek immediate medical attention.
Prolonged use of Vildapace M 500mg/50mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildapace M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if you're also taking insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Vildapace M 500mg/50mg Ta...
64
MRP 74
13% off